[HTML][HTML] The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli, JD Heiss… - Journal of Translational …, 2023 - Springer
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is one of
the most common and aggressive intracranial tumors in adults. Intratumoral heterogeneity …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

C Ramsoomair, M Ceccarelli, J Heiss… - Journal of Translational …, 2023 - europepmc.org
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.

CK Ramsoomair, M Ceccarelli… - Journal of …, 2023 - search.ebscohost.com
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

[HTML][HTML] The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli, JD Heiss… - Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

[HTML][HTML] The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli… - Journal of …, 2023 - … -medicine.biomedcentral.com
Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is one of
the most common and aggressive intracranial tumors in adults. Intratumoral heterogeneity …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.

CK Ramsoomair, M Ceccarelli, JD Heiss… - Journal of Translational …, 2023 - go.gale.com
Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is one of
the most common and aggressive intracranial tumors in adults. Intratumoral heterogeneity …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli… - Journal of …, 2023 - search.proquest.com
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

[PDF][PDF] The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses

CK Ramsoomair, M Ceccarelli… - Journal of …, 2023 - … -medicine.biomedcentral.com
Abstract Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is
one of the most common and aggressive intracranial tumors in adults. Intratumoral …

The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.

CK Ramsoomair, M Ceccarelli, JD Heiss… - Journal of Translational …, 2023 - europepmc.org
Glioblastoma (GBM) comprises 45.6% of all primary malignant brain cancers and is one of
the most common and aggressive intracranial tumors in adults. Intratumoral heterogeneity …